Compared to non‐HT patients, the A‐s‐HT subgroup had slightly decreased levels of vWF (5.76 ± 0.61 vs. 5.90 ± 0.63, p = 0.407), while s‐HT patients had a significant reduction (5.40 ± 0.62 vs. 5.90 ± 0.63, p = 0.016) (Table S1, Figure S1). Here, VWF is linked to hematocrit.